Skip to Main Content

Paper Details

Anti-Müllerian hormone for the diagnosis and prediction of menopause: a systematic review.
Hum Reprod Update
18
2023
AMH, Anti-Mllerian hormone, FSH, POI, amenorrhoea, anti-Mllerian hormone, cardiovascular disease, follicles, osteoporosis, patients, premature ovarian insufficiency, serum AMH, woman, women
Author NameAffiliation
Scott M NelsonUniversity of Glasgow
Scott M NelsonInstitute of Reproductive Sciences
Scott M NelsonNIHR Bristol Biomedical Research Centre, University of Bristol
Susan R DavisSchool of Public Health and Preventive Medicine, Monash University
Susan R Davis
Susan R DavisSchool of Public Health and Preventive Medicine, Monash University
Susan R Davis
Sophia N KalantaridouAttikon University Hospital, National and Kapodistrian University of Athens
Mary Ann LumsdenUniversity of Glasgow
Mary Ann Lumsden
Nick PanayQueen Charlotte's & Chelsea and Westminster Hospitals, Imperial College London
Richard A AndersonUniversity of Edinburgh
  • 1 - 12

Datasets

Dataset
Description
Source Link
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
Release 1.2